{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:45:59Z","timestamp":1784828759854,"version":"3.55.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001734","name":"University of Copenhagen","doi-asserted-by":"crossref","award":["29698"],"award-info":[{"award-number":["29698"]}],"id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To develop a physiologically based pharmacokinetic (PBPK) model for furosemide immediate release (IR) tablets and modified release (MR) capsules by coupling biorelevant dissolution testing results with pharmacokinetic (PK) and physiologic parameters, and to investigate the key factors influencing furosemide absorption using simulation approaches and the PBPK model.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using solubility, dissolution kinetics, gastrointestinal (GI) parameters and disposition parameters, a PBPK model for furosemide was developed with STELLA software. Solubility and dissolution profiles for both formulations were evaluated in biorelevant and compendial media. The simulated plasma profiles were compared with in-vivo profiles using point estimates of area under plasma concentration-time curve, maximal concentration after the dose and time to maximal concentration after the dose.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>Simulated plasma profiles of both furosemide IR tablets and MR capsules were similar to the observed in-vivo profile in terms of PK parameters. Sensitivity analysis of the IR tablet model indicated that both the gastric emptying and absorption rate have an influence on the plasma profile. For the MR capsules, the sensitivity analysis suggested that the release rate in the small intestine, gastric emptying and the absorption rate all have an influence on the plasma profile.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>A predictive model to describe both IR and MR dosage forms containing furosemide was attained. Because sensitivity analysis of the model is able to identify key factors influencing the plasma profile, this in-vitro\u2013in-silico\u2013in-vivo approach could be a useful tool for facilitating formulation development of drug products.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jphp.12365","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T09:43:08Z","timestamp":1422956588000},"page":"651-665","source":"Crossref","is-referenced-by-count":28,"title":["Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro\u2013in-silico\u2013in-vivo approach"],"prefix":"10.1093","volume":"67","author":[{"given":"Keiichi","family":"Otsuka","sequence":"first","affiliation":[{"name":"Institute of Pharmaceutical Technology, Goethe University , Frankfurt am Main,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wagner","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Technology, Goethe University , Frankfurt am Main,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Selen","sequence":"additional","affiliation":[{"name":"Office of New Drug Quality Assessment, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, United States Food and Drug Administration , Silver Spring, MD,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dressman","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Technology, Goethe University , Frankfurt am Main,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"2024103012491897500_jphp12365-cit-0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm Res"},{"key":"2024103012491897500_jphp12365-cit-0002","volume-title":"ICH Harmonized Tripartite Guideline. Pharmaceutical Development Q8 (R2)","author":"International Conference on Harmonization (ICH)","year":"2009"},{"key":"2024103012491897500_jphp12365-cit-0003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012491897500_jphp12365-cit-0004","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm Res"},{"key":"2024103012491897500_jphp12365-cit-0005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm Res"},{"key":"2024103012491897500_jphp12365-cit-0006","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejps.2004.11.007","article-title":"In vivo in vitro correlations for poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media","volume":"24","author":"Sunesen","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"2024103012491897500_jphp12365-cit-0007","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejps.2009.03.015","article-title":"Application of biorelevant dissolution tests to prediction of in vivo performance of dichlofenac sodium from an oral modified-release pellet dosage form","volume":"37","author":"Jantratid","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"2024103012491897500_jphp12365-cit-0008","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1023\/A:1011071401306","article-title":"Biorelevant dissolution testing to predict the plasma profile of lipophlic drug after oral administration","volume":"18","author":"Nicolaides","year":"2001","journal-title":"Pharm Res"},{"key":"2024103012491897500_jphp12365-cit-0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2009.05.009","article-title":"Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling","volume":"73","author":"Shono","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012491897500_jphp12365-cit-0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2010.10.012","article-title":"Biorelevant in vitro dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles","volume":"77","author":"Juenemann","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012491897500_jphp12365-cit-0011","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejpb.2012.12.001","article-title":"An in vitro\u2013in silico\u2013in vivo approach to predicting the oral pharmacokinetic profile of salts of weak acids: case example dantrolene","volume":"84","author":"Kambayashi","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012491897500_jphp12365-cit-0012","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/jphp.12059","article-title":"Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage forms","volume":"65","author":"Otsuka","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"2024103012491897500_jphp12365-cit-0013","volume-title":"Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System","author":"FDA","year":"2000"},{"key":"2024103012491897500_jphp12365-cit-0014","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jps.22030","article-title":"Biowaiver monographs for immediate release solid oral dosage forms: furosemide","volume":"99","author":"Granero","year":"2010","journal-title":"J Pharm Sci"},{"key":"2024103012491897500_jphp12365-cit-0015","first-page":"6","article-title":"The mini paddle apparatus \u2013 a useful tool in the early developmental stage? Experiences with immediate-release dosage forms","volume":"13","author":"Klein","year":"2006","journal-title":"Dissolut Thechnol"},{"key":"2024103012491897500_jphp12365-cit-0016","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00630286","article-title":"Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis","volume":"26","author":"Hammarlund","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"2024103012491897500_jphp12365-cit-0017","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1248\/bpb.19.616","article-title":"Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects","volume":"19","author":"Yagi","year":"1996","journal-title":"Biol Pharm Bull"},{"key":"2024103012491897500_jphp12365-cit-0018","volume-title":"Biopharmaceutics of Orally Administrated Drugs","author":"Macheras","year":"1995"},{"key":"2024103012491897500_jphp12365-cit-0019","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/jps.2600711006","article-title":"Disposition and absolute bioavailability of furosemide in healthy males","volume":"71","author":"Waller","year":"1982","journal-title":"J Pharm Sci"},{"key":"2024103012491897500_jphp12365-cit-0020","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.ejpb.2013.03.001","article-title":"Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro\u2013in silico\u2013in vivo approach","volume":"85","author":"Fei","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012491897500_jphp12365-cit-0021","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejpb.2010.05.009","article-title":"Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans","volume":"76","author":"Shono","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012491897500_jphp12365-cit-0022","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ejps.2004.11.005","article-title":"Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug","volume":"24","author":"Sunesen","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"2024103012491897500_jphp12365-cit-0023","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoritical basis for a biopharmaceutic drug classification: the correlation if in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm Res"},{"key":"2024103012491897500_jphp12365-cit-0024","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejpb.2011.04.005","article-title":"Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir","volume":"79","author":"Shono","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012491897500_jphp12365-cit-0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2012.05.008","article-title":"Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model","volume":"82","author":"Wagner","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"2024103012491897500_jphp12365-cit-0026","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00556898","article-title":"Implications of intraindividual variability in bioavailability studies of furosemide","volume":"27","author":"Grahnen","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"2024103012491897500_jphp12365-cit-0027","first-page":"G133","article-title":"Gastric emptying of ordinary food: effect of antrum on particle size","volume":"239","author":"Meyer","year":"1980","journal-title":"Am J Physiol"},{"key":"2024103012491897500_jphp12365-cit-0028","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s11095-009-9869-3","article-title":"Gastric emptying of pellets under fasting conditions: a mathematical model","volume":"26","author":"Locatelli","year":"2009","journal-title":"Pharm Res"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12365","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjphp.12365","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/67\/5\/651\/60228501\/jphp12365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/67\/5\/651\/60228501\/jphp12365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T18:14:23Z","timestamp":1730312063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/67\/5\/651\/6128214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,1]]},"published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jphp.12365","relation":{},"ISSN":["2042-7158","0022-3573"],"issn-type":[{"value":"2042-7158","type":"electronic"},{"value":"0022-3573","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,5]]},"published":{"date-parts":[[2015,5,1]]}}}